4
Changes in Ownership
AYTU BIOPHARMA, INC Filed Acc 0001209191-15-079940
Options or other derivatives
- Chief Executive Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Disbrow Joshua R. · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-11-11 | Grant or award : show line 1 in the form Employee Stock Option Grant | +600,000 | 600,000 | D |
Loading xslF345X03/doc4.xml…